pegfilgrastim

CHEBI:CHEBI_750961

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
pegfilgrastim
rxcui
2549333
dosage_form
INJECTION
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
marketing_start_date
20020401
package_marketing_start_date
20020401
route
SUBCUTANEOUS
marketing_category
BLA
labeler_name
Amneal Pharmaceuticals LLC
nui
N0000175666
pharm_class_epc
Leukocyte Growth Factor [EPC]
pharm_class
Granulocyte-Macrophage Colony-Stimulating Factor [CS]
pharm_class_pe
Increased Myeloid Cell Production [PE]
pharm_class_cs
Granulocyte Colony-Stimulating Factor [CS]
manufacturer_name
Amneal Pharmaceuticals LLC
brand_name
Fulphila
brand_name_base
Fulphila
product_ndc
55513-192
application_number
BLA761075
spl_id
85a107b2-3583-48e8-a205-79e4bbd3b2a5
active_ingredient_name
PEGFILGRASTIM
active_ingredient_strength
6 mg/.6mL
package_ndc
55513-192-01
package_description
1 KIT in 1 CARTON (55513-192-01) * .6 mL in 1 SYRINGE
unii
3A58010674
spl_set_id
fdfe5d72-6b80-435a-afa4-c5d74dd852ce
upc
0370121162711
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class